C. Gibson

发表

Angiographic outcomes with early eptifibatide therapy in non-ST-segment elevation acute coronary syndrome (from the EARLY ACS Trial).

R. Califf, R. Giugliano, E. Braunwald, 2014, The American journal of cardiology.

Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy.

M. Sabatine, Yuri B. Pride, Claudia P. Hochberg, 2009, Journal of the American College of Cardiology.

Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes

R. Giugliano, M. Sabatine, E. Braunwald, 2005, Circulation.

The effect of rivaroxaban on myocardial infarction in the ATLAS ACS 2 - TIMI 51 trial

J. Mega, E. Braunwald, S. Murphy, 2015, European heart journal. Acute cardiovascular care.

Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndromes

E. Antman, M. Sabatine, E. Braunwald, 2003, Circulation.

The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies.

E. Antman, M. Sabatine, E. Braunwald, 2002, Journal of the American College of Cardiology.

The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study.

R. Giugliano, M. Sabatine, E. Braunwald, 2006, Journal of the American College of Cardiology.

Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial.

Eric Peterson, David A Morrow, David J Cohen, 2006, Journal of the American College of Cardiology.

Association of Epicardial and Tissue-Level Reperfusion with Left Ventricular End-Diastolic Pressures in ST-Elevation Myocardial Infarction

E. Antman, R. Giugliano, C. Cannon, 2004, Journal of Thrombosis and Thrombolysis.

Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.

M. Sabatine, S. Murphy, P. Zimetbaum, 2008, Journal of the American College of Cardiology.

Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.

M. Eren, C. Gibson, M. Ergelen, 2012, The American journal of cardiology.

Thrombolytics and myocardial infarction.

C. Gibson, Vijayalakshmi Kunadian, 2012, Cardiovascular therapeutics.

Urinary albumin concentration and long-term cardiovascular risk in acute coronary syndrome patients: a PROVE IT-TIMI 22 substudy

C. Cannon, S. Murphy, C. Gibson, 2013, Journal of Thrombosis and Thrombolysis.

Benefit of Transferring ST-Segment–Elevation Myocardial Infarction Patients for Percutaneous Coronary Intervention Compared With Administration of Onsite Fibrinolytic Declines as Delays Increase

T. Henry, A. Kirtane, C. Gibson, 2011, Circulation.

Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction.

E. Antman, R. Giugliano, E. Braunwald, 1999, Journal of the American College of Cardiology.

Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study).

M. Sabatine, C. Cannon, A. Kirtane, 2008, The American journal of cardiology.

High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14.

E. Antman, R. Giugliano, E. Braunwald, 2000, Circulation.

Elevations in Troponin T and I Are Associated With Abnormal Tissue Level Perfusion: A TACTICS-TIMI 18 Substudy

C. Cannon, D. Morrow, S. Murphy, 2002, Circulation.

Intracoronary pharmacotherapy in the management of coronary microvascular dysfunction

W. Gibson, Jacqueline Buros, C. Gibson, 2008, Journal of Thrombosis and Thrombolysis.

Distance from the Coronary Ostium to the Culprit Lesion in Acute ST-Elevation Myocardial Infarction and its Implications Regarding the Potential Prevention of Proximal Plaque Rupture

Ajay J. Kirtane, Robert P. Giugliano, Robert A. Harrington, 2003, Journal of Thrombosis and Thrombolysis.

Myonecrosis following stent placement: association between impaired TIMI myocardial perfusion grade and MRI visualization of microinfarction.

R. Kim, S. Murphy, C. Gibson, 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.

M. Sabatine, E. Braunwald, C. Cannon, 2008, American heart journal.

Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome.

A. Kirtane, D. Morrow, S. Murphy, 2006, The American journal of cardiology.

Correlates and prognostic impact of new-onset heart failure after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: insights from the INFUSE-AMI trial

G. Stone, A. Kirtane, D. Dudek, 2018, European heart journal. Acute cardiovascular care.

Association of lesion complexity following fibrinolytic administration with mortality in ST-elevation myocardial infarction.

E. Antman, R. Giugliano, C. Cannon, 2004, The American journal of cardiology.